希格生科创始人兼CEO张海生博士受邀在老牌生化学报《Acta Biochimica et Biophysica Sinica》上发表封面文章，作为共同通讯作者提出了癌症化疗连用的新主张。
论文及其链接：
Yu, M., Lun, J., Zhang, H., Wang, L., Zhang, G., Zhang, H., & Fang, J. (2021). Targeting UPR branches, a potential strategy for enhancing efficacy of cancer chemotherapy. Acta Biochimica Et Biophysica Sinica, 53(11), 1417–1427.
https://doi.org/10.1093/abbs/gmab131